ACZAcetazolamidefurosemideHFheart failure
…ship of baseline characteristics to response in those receiving ACZ. Results are displayed as odds ratio (95% confidence interval).…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 119 of 2459BNPNICEHeart FailureSouthern Health and Social Care TrustHFSHSCTRAHFCleft-sided HF
…have recommended that patients with a BNP>2000 and those with a BNP 400-2000, should be reviewed by a HF specialist within two and …
NICEaortic stenosisGLP-1 receptor agoniststype 2 diabetesaortic valve diseaseobesity
… surgical aortic valve replacement at a single tertiary centre. NICE eligibility for GLP-1 receptor agonist therapy was determined b…
HCChepatocellular carcinomaClinicalTrials. govAffiliated Cancer Hospital of Shandong First Medical UniversitySLSTFLSTradiotherapysecond-line systemic therapyRT
… with an early switch to SLST in patients with oligoprogressive HCC while maintaining an acceptable safety profile.Methods and anal…
SSc-RPAISA-021SScSLE-RPNature Biomed EngincilnidipineRA-RPILD
…d here. Placebo group positive response occurred as in previous SSc-RP trials. Unblinded results will be presented at the Congress Mee…
SScfibrosisrTOPORennes university HospitalNaClautoimmunity
… tended to increase their levels.Conclusions SiO2 inhalation in SSc patients was associated with a more severe phenotype, including…
calcinosisActivin Asystemic sclerosis (SSc)CD206 antagonistRCD SystemsSSc
…stic studies and therapeutic testing. Ongoing work with excised calcinosis samples, analysed by immunochemistry, will further link macroph…
bosentansystemic sclerosis (SSc)digital ulcersmethotrexateImmunosuppressive therapymycophenolate mofetilMTXDigital ulcers (DUs)
…development of a new digital ulcer despite at least 24 weeks of bosentan therapy. We included patients who were receiving concurrent tre…
systemic sclerosis (SSc)cyclophosphamidefludarabineSSc-Skin-1rese-celSSc-Skin-2SSc-Skin-1AbstractNCT06328777
…Introduction Treatment goals for systemic sclerosis (SSc) include controlling disease activity, limiting progression of o…
Health Assessment QuestionnaireefgartigimodSystemic SclerosisSystemic sclerosis (SSc)recombinant human hyaluronidase PH20NCT06655155rHuPH20interstitial lung diseasepulmonary arterial hypertension
…ssification as per 2013 ACR/EULAR criteria, ANA seropositivity, Health Assessment Questionnaire-Disability Index (HAQ-DI) score of at least 0.5 or Patient Glob…
systemic sclerosisincurable cancerSScEarly palliative careearly palliative care
… P.302 Figure 1ESAS-r prevalence of moderate-severe symptoms in systemic sclerosis vs incurable cancer…
NSCLCosimertinibmetastatic non-small cell lung cancerSABRLCTEGFR-mutated disease
…ess of consolidation. In driver-negative, immunotherapy-treated NSCLC, early phase and real-world series suggest that carefully selec…